1502 related articles for article (PubMed ID: 12733982)
1. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
Bertolini A; Ottani A; Sandrini M
Curr Med Chem; 2002 May; 9(10):1033-43. PubMed ID: 12733982
[TBL] [Abstract][Full Text] [Related]
2. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
3. Dual acting anti-inflammatory drugs.
Leone S; Ottani A; Bertolini A
Curr Top Med Chem; 2007; 7(3):265-75. PubMed ID: 17305569
[TBL] [Abstract][Full Text] [Related]
4. Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy?
Fiorucci S; Meli R; Bucci M; Cirino G
Biochem Pharmacol; 2001 Dec; 62(11):1433-8. PubMed ID: 11728379
[TBL] [Abstract][Full Text] [Related]
5. The metabolic effects of inhibitors of 5-lipoxygenase and of cyclooxygenase 1 and 2 are an advancement in the efficacy and safety of anti-inflammatory therapy.
Celotti F; Durand T
Prostaglandins Other Lipid Mediat; 2003 Jul; 71(3-4):147-62. PubMed ID: 14518558
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory drugs: new multitarget compounds to face an old problem. The dual inhibition concept.
Celotti F; Laufer S
Pharmacol Res; 2001 May; 43(5):429-36. PubMed ID: 11394934
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 inhibition and side-effects of non-steroidal anti-inflammatory drugs in the gastrointestinal tract.
Meyer-Kirchrath J; Schrör K
Curr Med Chem; 2000 Nov; 7(11):1121-9. PubMed ID: 11032962
[TBL] [Abstract][Full Text] [Related]
8. Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs.
Charlier C; Michaux C
Eur J Med Chem; 2003; 38(7-8):645-59. PubMed ID: 12932896
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2-selective inhibitors: translating pharmacology into clinical utility.
Cronstein BN
Cleve Clin J Med; 2002; 69 Suppl 1():SI13-9. PubMed ID: 12086289
[TBL] [Abstract][Full Text] [Related]
10. Current perspective on the cardiovascular effects of coxibs.
Konstam MA; Weir MR
Cleve Clin J Med; 2002; 69 Suppl 1():SI47-52. PubMed ID: 12086293
[TBL] [Abstract][Full Text] [Related]
11. [Non-steroidal anti-inflammatory agents with selective inhibitory activity on cyclooxygenase-2. Interest and future prospects].
Blain H; Jouzeau JY; Netter P; Jeandel C
Rev Med Interne; 2000 Nov; 21(11):978-88. PubMed ID: 11109595
[TBL] [Abstract][Full Text] [Related]
12. Non steroidal anti-inflammatory and anti-allergy agents.
Kontogiorgis CA; Hadjipavlou-Litina DJ
Curr Med Chem; 2002 Jan; 9(1):89-98. PubMed ID: 11860351
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of nonsteroidal anti-inflammatory drug-induced gastrointestinal injury and repair: a window of opportunity for cyclooxygenase-inhibiting nitric oxide donors.
Perini R; Fiorucci S; Wallace JL
Can J Gastroenterol; 2004 Apr; 18(4):229-36. PubMed ID: 15054499
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory drugs in the 21st century.
Rainsford KD
Subcell Biochem; 2007; 42():3-27. PubMed ID: 17612044
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review.
Hooper L; Brown TJ; Elliott R; Payne K; Roberts C; Symmons D
BMJ; 2004 Oct; 329(7472):948. PubMed ID: 15475342
[TBL] [Abstract][Full Text] [Related]
16. COX-2 inhibitors. What is their place?
McGettigan P
Aust Fam Physician; 2000 Sep; 29(9):847-52. PubMed ID: 11008387
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal effects of nonsteroidal anti-inflammatory drugs.
Whittle BJ
Fundam Clin Pharmacol; 2003 Jun; 17(3):301-13. PubMed ID: 12803569
[TBL] [Abstract][Full Text] [Related]
18. Novel non-steroidal anti-inflammatory drugs: what we have learned from animal studies.
Coruzzi G; Menozzi A; Dobrilla G
Curr Drug Targets Inflamm Allergy; 2004 Mar; 3(1):43-61. PubMed ID: 15032641
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of COX-2 inhibitors in arthritis.
Jackson CG
Expert Opin Investig Drugs; 2001 Jul; 10(7):1317-25. PubMed ID: 11772254
[TBL] [Abstract][Full Text] [Related]
20. Clinical perspectives of anti-inflammatory therapy in the elderly: the lipoxigenase (LOX)/cycloxigenase (COX) inhibition concept.
Gaddi A; Cicero AF; Pedro EJ
Arch Gerontol Geriatr; 2004; 38(3):201-12. PubMed ID: 15066307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
